Mutation
The putative cancer-causing PDGs driven by somatic mutations were predicted by integration of five complementary methods to identify the genes with mutations that have significant signs of positive selection during tumor evolution.
| Showing page 11 |
first page | previous page | next page | last page |
| HGNC Symbol | Ensembl Gene ID | Overall_Mscore | No. of Cancer Types |
| SLC20A2 | ENSG00000168575 | 0.00 | 0 |
| CLSTN1 | ENSG00000171603 | 0.02 | 1 |
| CLCN6 | ENSG00000011021 | 0.00 | 0 |
| LPAR6 | ENSG00000139679 | 0.00 | 0 |
| GPC1 | ENSG00000063660 | 0.00 | 0 |
| SLC2A5 | ENSG00000142583 | 0.00 | 0 |
| ALPL | ENSG00000162551 | 0.00 | 0 |
| CRELD2 | ENSG00000184164 | 0.00 | 0 |
| ARSA | ENSG00000100299 | 0.00 | 0 |
| GPR157 | ENSG00000180758 | 0.00 | 0 |
| TNFRSF1B | ENSG00000028137 | 0.00 | 0 |
| SLC45A1 | ENSG00000162426 | 0.00 | 0 |
| MFSD12 | ENSG00000161091 | 0.00 | 0 |
| SLC9A1 | ENSG00000090020 | 0.00 | 0 |
| TNFRSF10B | ENSG00000120889 | 0.00 | 0 |
| TYRO3 | ENSG00000092445 | 0.00 | 0 |
| TNFRSF10A | ENSG00000104689 | 0.00 | 0 |
| SLC39A14 | ENSG00000104635 | 0.00 | 0 |
| SLC30A5 | ENSG00000145740 | 0.00 | 0 |
| GPR153 | ENSG00000158292 | 0.00 | 0 |
|
Showing page 11 |
first page | previous page | next page | last page |